Imperial Biomedic Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.90 M
- Company Age 32 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.22 M
- Revenue Growth 9.26%
- Profit Growth 31.22%
- Ebitda 23.45%
- Net Worth -1.14%
- Total Assets 0.04%
About Imperial Biomedic
Imperial Biomedic Pvt Ltd (IBPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 July 1992 and has a history of 32 years and six months. Its registered office is in Ut, Chandigarh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹0.22 M.
Neeraj Gupta and Prem Gupta serve as directors at the Company.
Company Details
- Location Ut, Chandigarh
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51397CH1992PTC012504
-
Company No.
012504
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Jul 1992
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Imperial Biomedic Pvt Ltd offer?
Imperial Biomedic Pvt Ltd offers a wide range of products and services, including Laboratory & Lab Equipment, Laboratory Equipment, Audio Mixer, Recorder & Transmitter, Outdoor Speaker.
Who are the key members and board of directors at Imperial Biomedic?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Gupta
|
Director | 04-Feb-1994 | Current |
|
Prem Gupta
|
Director | 15-Jan-2000 | Current |
Financial Performance of Imperial Biomedic.
Imperial Biomedic Pvt Ltd, for the financial year ended 2021, experienced modest growth in revenue, with a 9.26% increase. The company also saw a substantial improvement in profitability, with a 31.22% increase in profit. The company's net worth dipped by a decrease of 1.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Imperial Biomedic?
In 2021, Imperial Biomedic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Genes 2Me Private LimitedNeeraj Gupta is a mutual person
-
Imperial Life Sciences Private LimitedNeeraj Gupta and Prem Gupta are mutual person
-
Ils FoundationNeeraj Gupta is a mutual person
Charges (Loans)
₹0.22 M
₹0
Charges Breakdown by Lending Institutions
- Fiat Sundaram Auto Finance Ltd. : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2002 | Fiat Sundaram Auto Finance Ltd. | ₹0.22 M | Open |
How Many Employees Work at Imperial Biomedic?
Unlock and access historical data on people associated with Imperial Biomedic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Imperial Biomedic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imperial Biomedic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
